Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Wormwood transcriptome testing program

PROVIDER: PRJNA1065585 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR27586300_1.fastq.gz	Fastqsanger.gz
	SRR27586300_2.fastq.gz	Fastqsanger.gz
	SRR27586301_1.fastq.gz	Fastqsanger.gz
	SRR27586301_2.fastq.gz	Fastqsanger.gz
	SRR27586302_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24

Similar Datasets

Project description:Caenorhabditis Intervention Testing Program (CITP) diversity panel

| PRJNA773598 | ENA

Integrated multi-omics for rapid rare disease diagnosis on a national scale

Project description:The Australian Acute Care Genomics program provides ultra-rapid diagnostic testing to critically ill infants and children with suspected genetic conditions. Over two years, we performed whole genome sequencing (WGS) in 290 families, with average time to result of 2.9 days, and diagnostic yield of 47%. We performed additional bioinformatic analyses and transcriptome sequencing in all patients who remained undiagnosed. Long-read sequencing and functional assays, ranging from clinically accredited enzyme analysis to bespoke quantitative proteomics, were deployed in selected cases. This resulted in an additional 19 diagnoses, and an overall diagnostic yield of 54%. Diagnostic variants ranged from structural chromosomal abnormalities through to an intronic retrotransposon, disrupting splicing. Critical care management changed in 120 diagnosed patients (77%). Results informed precision treatments; surgical and transplant decisions; and palliation in 94 (60%). We propose that integration of multi-omic approaches into mainstream diagnostic practice is necessary to realise the full potential of genomic testing.

2023-10-24 | PXD042001 | Pride

Profiling whole lung from Ovalbumin (OVA)-challenged and control BALB/c mice

Project description:This program aims at identifying the lung gene signature associated with OVA-challenged mouse asthma model to facilitate understanding of the disease mechanism and therapeutic compound testing

2013-03-22 | GSE31949 | GEO

Childhood Cancer Data Initiative (CCDI): Pediatric In Vivo Testing Program – Neuroblastoma

Project description:Childhood Cancer Data Initiative (CCDI): Pediatric In Vivo Testing Program – Neuroblastoma

| PRJNA915180 | ENA

Childhood Cancer Data Initiative (CCDI): Pediatric In Vivo Testing Program – Neuroblastoma

Project description:Childhood Cancer Data Initiative (CCDI): Pediatric In Vivo Testing Program – Neuroblastoma

| PRJNA915179 | ENA

Project description:testing testing

| PRJNA769659 | ENA

Profiling whole lung from lung-specific IL-1b-Tg mice

Project description:This program aims at identifying the lung gene signature associated with inflammation and emphysema in IL-1b-Tg mouse COPD model to facilitate understanding of the disease mechanism and therapeutic compound testing

2013-03-22 | GSE38075 | GEO

Moderate-level resistance exercise significantly improved the Sickness Impact Profile ALS-19 and muscle transcriptome of the early-stage ALS patients.

Project description:Amyotrophic lateral sclerosis (ALS) patients lose motor and neuromuscular function but lack effective treatments. The objective of this study was to evaluate the effect of moderate-level exercise on ALS scores, neuromuscular function, and transcriptome in ALS patients. Methods: A pilot open-label, non-randomized clinical trial was conducted in seven individuals with early-stage ALS. Participants were given three months of moderate-level home-based resistance exercise focusing on the quadriceps muscles. Before and after the exercise program, participants were evaluated by quantifiable outcome measures using bilateral quadriceps strength with manual muscle testing and handheld dynamometers and functional outcome measures using five times sit-to-stand and Timed-Up-and-Go. In addition, changes in the transcriptome and mitochondrial respiration of exercised muscles were compared before and after the exercise. Results: The exercise program significantly improved the Sickness Impact Profile ALS-19 (SIP/ALS-19) and did not cause serious adverse events to the patients. ALSFRS-R, quantifiable outcome measures, functional outcome measures, and muscle respiration values did not change by the exercise program. Transcriptome analysis revealed that exercise reverted the expression level of genes decreased in ALS, including PVALB. Conclusions: Three months of moderate-level resistance exercise is not detrimental for the patients and may have a positive effect on patients’ QOL.

2024-09-25 | GSE250455 | GEO

BIG MS Pilot

Project description:Testing logistics and infrastructure of molecular screening program. Core biopsies taken from invasive recurrent or metastatic breast cancer to evaluate and identify molecular traits rendering them suitable for clinical trials

| EGAS00001000616 | EGA

EGAS00001000616-sc-20140619 - samples

| EGAD00001000870 | EGA